Thyrocare Technologies’ shares slumped 66.7% to ₹492 on Friday as they began trading ex-bonus for the recently announced 2:1 bonus issue. The sharp drop is a normal adjustment due to the bonus issue and doesn’t indicate any deterioration in fundamentals.
Can Moneyview IPO deliver long-term growth for high-risk investors?
Moneyview, a digital lending platform, is planning a ₹750 crore IPO to fund loan growth. The company’s registered users increased significantly, but asset quality has